Metabolic adaptations of cells at the vascular-immune interface during atherosclerosis

• Published in: Molecular aspects of medicine 2021-02, Vol.77, p.100918-100918, Article 100918
• Main Authors: Bonacina, F., Da Dalt, L., Catapano, A.L., Norata, G.D.
• Format: Article
• Language: English
• Subjects: Atherosclerosis; Endothelial Cells; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Plaque, Atherosclerotic
• ISSN: 0098-2997; 1872-9452
• DOI: 10.1016/j.mam.2020.100918

Metabolic reprogramming is a physiological cellular adaptation to intracellular and extracellular stimuli that couples to cell polarization and function in multiple cellular subsets. Pathological conditions associated to nutrients overload, such as dyslipidaemia, may disturb cellular metabolic homeostasis and, in turn, affect cellular response and activation, thus contributing to disease progression. At the vascular/immune interface, the site of atherosclerotic plaque development, many of these changes occur. Here, an intimate interaction between endothelial cells (ECs), vascular smooth muscle cells (VSMCs) and immune cells, mainly monocytes/macrophages and lymphocytes, dictates physiological versus pathological response. Furthermore, atherogenic stimuli trigger metabolic adaptations both at systemic and cellular level that affect the EC layer barrier integrity, VSMC proliferation and migration, monocyte infiltration, macrophage polarization, lymphocyte T and B activation. Rewiring cellular metabolism by repurposing “metabolic drugs” might represent a pharmacological approach to modulate cell activation at the vascular immune interface thus contributing to control the immunometabolic response in the context of cardiovascular diseases. [Display omitted]